Back to event listing

Buprenorphine Waiver Training

8:00am - October 22, 2019
Pacific Southwest ATTC

ASU Tucson Campus
340 N. Commerce Park Loop, Suite 250
Tucson, AZ 85745
United States

Registration Deadline: October 22, 2019
Need more information?
Contact us at cabhp@asu.edu

To prescribe buprenorphine, one of three medications approved by the FDA for the treatment of opioid use disorder, physicians are required to complete 8 hours of training in order to apply to the Drug Enforcement Agency for a waiver. This course will provide prescribers with the 8 hours of required MAT training. Following completion of the course, attendees will be given a link to complete the remainder of the training at no cost from the Providers Clinical Support System (PCSS). Nurse Practitioners (NP) and Physician assistants (PA) are required to complete 24 hours of training including the 8 hour MAT training.  This event has been approved by the Office of Continuing Medical Education and has been awarded a maximum of 8 AMA PRA Category 1 Credit(s). Please contact cabhp@asu.edu with any questions.

American Academy of Addiction Psychiatry is the Data Sponsor for this training. Funding for this course was made possible (in part) by 1U79TI026556 from SAMHSA. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government.  Additional Funding Attribution: Arizona State Opioid Response (SOR) grant, Arizona Health Care Cost Containment System, Substance Abuse and Mental Health Services Administration, grant #T1081709-01.

Registration: Free. Please email cabhp@asu.edu for questions.

Registration Link: https://www.eiseverywhere.com/ehome/index.php?eventid=482108&